Alisertib
Alisertib is an orally available Drug with potential antineoplastic activity. It is a selective inhibitor of aurora A kinase developed by Takeda. Reference standards of Alisertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Alisertib
[catalogue_number] => PA 01 2730000
[category_ids] => ,123,81,78,75,76,82,
[chemical_name] =>
[weight] => 518.93
[form] => C27H20ClFN4O4
[cas] => 1028486-01-2
[pslug] => 1028486-01-2-alisertib-pa012730000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 01 2730000
Molecular Formula : C27H20ClFN4O4
Molecular Weight : 518.93